Avacta provides update on COVID-19 antigen diagnostic test development with Adeptrix
Highly specific prototype test detects the virus spike protein at clinically relevant concentrations
Highly specific prototype test detects the virus spike protein at clinically relevant concentrations
The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications
Our expert webinar series aims to help you get the most from your drug discovery research
The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19
This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic
Hybrid nanocapsules from renewable material hope to help cut carbon emissions
Deal enables a wider suite of pre-clinical testing services in oncology
New kits support analysis of all organs and species on fresh/fixed frozen and FFPE samples
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
A rare lung disease drug is being trialed to help fight COVID-19
Automated “lateral flow” dispensing technology is vital step in rapid point-of-care antibody test production